v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
CASH FLOWS FROM OPERATING ACTIVITIES:          
Net income (loss)     $ (11,184,200) $ 728,079  
Adjustments to reconcile income (loss) to net cash used in operating activities:          
Depreciation and amortization $ 515,365 $ 277,555 925,824 559,525  
Accretion of asset retirement obligation     65,029 38,967  
Noncash operating lease expense       244,510  
Share-based compensation     7,738,892 832,297  
Accretion income from investment securities held to maturity     (386,648) (95,990)  
Paid-in-kind interest from notes receivable     (127,276)    
Gain on sale or disposal of property, plant and equipment, net     (1,900) (500)  
Equity in losses of joint venture 56,514   72,640    
Write-down of inventory to net realizable value     161,456 0  
Change in allowance for credit losses     436 884  
Unrealized gain on investment in equity securities (6,786,253) 0 (2,724,823) 0  
Changes in operating assets and liabilities:          
Accounts receivable     1,605,182 (1,387,733)  
Inventories     (9,601,887) (5,566,803)  
Prepaid expenses and other current assets     (1,877,748) (1,249,047)  
IVA receivable and other assets       (483,360)  
Accounts payable     (4,473,542) 4,201,001  
Accrued liabilities     (896,562) (126,279)  
Accrued liabilities - directors     (15,056) (52,537)  
Net cash used in operating activities     (20,720,183) (2,356,986)  
CASH FLOWS FROM INVESTING ACTIVITIES:          
Proceeds from maturity of debt securities held to maturity     1,301,000    
Purchases of debt securities held to maturity     (1,294,726) (9,991,259)  
Proceeds from note receivable principal payment     100,000    
Additional advance under convertible note receivable     (1,116,154)   $ (2,500,000)
Proceeds from sales of property, plant and equipment     1,900 500  
Investment in joint venture     (149,000)    
Proceeds from government grant related to capital expenditures     12,848,246    
Purchases of property, plant and equipment     (22,813,341) (7,394,073)  
Net cash used in investing activities     (11,122,075) (17,384,832)  
CASH FLOWS FROM FINANCING ACTIVITIES:          
Principal payments on long-term debt     (71,777) (65,550)  
Proceeds from exercises of stock options     259,501 55,000  
Treasury stock acquired     (7,782,194)    
Proceeds from issuance of common stock, net of issuance costs     49,070,838 5,064,483  
Proceeds from exercise of warrants     1,963,812 2,225,411  
Net cash provided by financing activities     43,440,180 7,279,344  
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS AND RESTRICTED CASH     11,597,922 (12,462,474)  
CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AT BEGINNING OF PERIOD     30,657,076 18,270,898 18,270,898
CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AT END OF PERIOD $ 42,254,998 $ 5,808,424 42,254,998 5,808,424 $ 30,657,076
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:          
Interest paid in cash     64,357 5,243  
NON-CASH FINANCING AND INVESTING ACTIVITIES:          
Recognition of operating lease liability and right-of-use asset       $ 63,416  
Equipment purchased with note payable     211,127    
Property and equipment included in accounts payable / accrued liabilities     $ 1,823,977